AIP / Arteris, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance CAMPBELL, Calif.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 5, 2025 ARTERIS, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 5, 2025 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 3, 2025 ARTERIS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 3, 2025 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number

Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2025 Guidance

Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2025 Guidance CAMPBELL, Calif.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 13, 2025 ARTERIS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 13, 2025 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2025 ARTERIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numbe

Power of Attorney. Reference is made to the signature page to the Registration Statement.

As filed with the Securities and Exchange Commission on February 18, 2025 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-409

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Table Form S-8 (Form Type) Arteris, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity  Common stock, $0.001 par value p

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 18, 2025 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File N

Insider Trading Compliance Policy and Procedures

Exhibit 97.1 Arteris Insider Trading Compliance Policy and Procedures Effective February 27, 2023 Federal and state laws prohibit trading in the securities of a company while in possession of material nonpublic information and in breach of a duty of trust or confidence. These laws also prohibit anyone who is aware of material nonpublic information from providing this information to others who may

Subsidiaries of Arteris, Inc.

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People’s Republic of China Arteris IP Korea Limited Korea Arteris K.K. Japan Arteris IP SAS France Arteris HK Limited Hong Kong Arteris Poland Spółka z ograniczoną odpowiedzialnością also known as Arteris Poland Sp. z o.o. Poland Sauternes Merger Sub

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2024 and Estimated First Quarter and Full Year 2025 Guidance

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2024 and Estimated First Quarter and Full Year 2025 Guidance CAMPBELL, Calif.

AIP / Arteris, Inc. / Ventech Capital F - SC 13G/A Passive Investment

SC 13G/A 1 d294128dsc13ga.htm SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 5, 2024 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Nu

Arteris Announces Financial Results for the Third Quarter 2024 and Fourth Quarter and Full Year 2024 Guidance

Arteris Announces Financial Results for the Third Quarter 2024 and Fourth Quarter and Full Year 2024 Guidance CAMPBELL, Calif.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): September 13, 2024 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 1, 2024 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numb

Arteris Announces Financial Results for the Second Quarter 2024 and Third Quarter and Full Year 2024 Guidance

Arteris Announces Financial Results for the Second Quarter 2024 and Third Quarter and Full Year 2024 Guidance CAMPBELL, Calif.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Amended and Restated

Exhibit 10.1 ARTERIS INC. AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENT This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between [] (“Executive”) and Arteris Inc. (the “Company”), effective as of [the latest date set forth by the signatures of the parties hereto below]/[the date Executive commences employment with the Company] (the “

AIP / Arteris, Inc. / NEEDHAM INVESTMENT MANAGEMENT LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 4, 2024 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number

Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance

Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance CAMPBELL, Calif.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 2, 2024 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi

Subsidiaries of Arteris, Inc.

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People’s Republic of China Arteris IP Korea Limited Korea Arteris K.K. Japan Arteris IP SAS France Arteris HK Limited Hong Kong Sauternes Merger Sub II, LLC Delaware

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 20, 2024 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File N

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2023 and Estimated First Quarter and Full Year 2024 Guidance

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2023 and Estimated First Quarter and Full Year 2024 Guidance CAMPBELL, Calif.

Policy Relating to Recovery of Erroneously Awarded Compensation

Exhibit 97.1 ARTERIS, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Arteris, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11. 1.Persons Subject to Policy This Policy shal

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Table Form S-8 (Form Type) Arteris, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, $0.001 par value  p

As filed with the Securities and Exchange Commission on February 20, 2024

As filed with the Securities and Exchange Commission on February 20, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-409

AIP / Arteris, Inc. / Bayview Legacy, LLC - SC 13G/A Passive Investment

SC 13G/A 1 d738690dsc13ga.htm SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities)

AIP / Arteris, Inc. / Ventech Capital F - SC 13G/A Passive Investment

SC 13G/A 1 d870901dsc13ga.htm SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities)

Arteris Announces Financial Results for the Third Quarter 2023 and Fourth Quarter and Full Year 2023 Guidance

Arteris Announces Financial Results for the Third Quarter 2023 and Fourth Quarter and Full Year 2023 Guidance CAMPBELL, Calif.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 7, 2023 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 3, 2023 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numb

Arteris Announces Financial Results for the Second Quarter 2023 and Estimated Third Quarter and Full Year 2023 Guidance

Arteris Announces Financial Results for the Second Quarter 2023 and Estimated Third Quarter and Full Year 2023 Guidance CAMPBELL, Calif.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 6, 2023 ARTERIS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 6, 2023 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 4, 2023 ARTERIS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 4, 2023 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number)

Arteris Announces Financial Results for the First Quarter 2023 and Estimated Second Quarter and Full Year 2023 Guidance

Arteris Announces Financial Results for the First Quarter 2023 and Estimated Second Quarter and Full Year 2023 Guidance CAMPBELL, Calif.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 4, 2023 ARTERIS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 4, 2023 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 23, 2023 Arteris, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 23, 2023 Arteris, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numbe

Letter from Moss Adams LLP to the Securities and Exchange Commission dated March 24, 2023.

EX-16.1 Exhibit 16.1 March 24, 2023 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Arteris, Inc. included under Item 4.01(a) of its Current Report on Form 8-K dated March 23, 2023, to be filed with the Securities and Exchange Commission on March 27, 2023. We agree with the statements concerning our Firm cont

Subsidiaries of Arteris, Inc.

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People’s Republic of China Arteris IP Korea Limited Korea Arteris K.K. Japan Arteris IP SAS France Arteris HK Limited Hong Kong Sauternes Merger Sub II, LLC Delaware

Form 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-409

Power of Attorney. Reference is made to the signature page to the Registration Statement.

S-8 As filed with the Securities and Exchange Commission on March 1, 2023 Registration No.

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Table Form S-8 (Form Type) Arteris, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, $0.001 par value pe

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2022 and Estimated First Quarter and Full Year 2023 Guidance

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2022 and Estimated First Quarter and Full Year 2023 Guidance CAMPBELL, Calif.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 28, 2023 ARTERIS, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 28, 2023 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File N

US04302A1043 / Arteris, Inc. / Ventech Capital F - SC 13G/A Passive Investment

SC 13G/A 1 d433383dsc13ga.htm SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities)

US04302A1043 / Arteris, Inc. / Bayview Legacy, LLC - SC 13G/A Passive Investment

SC 13G/A 1 d422223dsc13ga.htm SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities)

Arteris, Inc. 595 Millich Dr. Suite 200 Campbell, CA 95008

Arteris, Inc. 595 Millich Dr. Suite 200 Campbell, CA 95008 November 30, 2022 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Jenny O?Shanick Re: Arteris, Inc. Registration Statement on Form S-3 Filed November 9, 2022 File No. 333-268257 To the addressee set forth

Form of Indenture

Exhibit 4.2 ARTERIS, INC. INDENTURE Dated as of , 20 [], as Trustee TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1. Definitions 1 Section 1.2. Other Definitions 4 Section 1.3. Incorporation by Reference of Trust Indenture Act 4 Section 1.4. Rules of Construction 5 ARTICLE II. THE SECURITIES 5 Section 2.1. Issuable in Series 5 Section 2.2. Establishment o

Open Market Sale AgreementSM, dated November 8, 2022, by and between Arteris Inc. and Jefferies LLC.

Exhibit 1.2 OPEN MARKET SALE AGREEMENTSM November 8, 2022 JEFFERIES LLC 520 Madison Avenue New York, New York 10022 Ladies and Gentlemen: Arteris, Inc., a Delaware corporation (the ?Company?), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the ?Agent?), shares of the Company?s common stock, pa

Filing Fee Table

EX-FILING FEES 4 d414780dexfilingfees.htm EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Arteris, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Share (2) Maximum Aggregate Offering Price Fee Rate Amo

Fee Table Exhibit

Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Arteris, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry F

Power of Attorney (included in the signature page to this registration statement).

Registration No. 333- As filed with the Securities and Exchange Commission on November 8, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Arteris, Inc. (Exact name of registrant as specified in its charter) Delaware 3674 27-0117058 (State or other jurisdiction of incorporation or organization) (Primary St

Powers of Attorney (incorporated by reference to the signature page hereto)

Table of Contents As filed with the Securities and Exchange Commission on November 8, 2022 Registration No.

Form of Stock Option Grant Notice and Stock Option Agreement under the 2022 Employment Inducement Award Plan

ARTERIS INC. 2022 EMPLOYMENT INDUCEMENT INCENTIVE PLAN STOCK OPTION GRANT NOTICE Arteris Inc., a Delaware corporation, (the ?Company?), pursuant to its 2022 Employment Inducement Incentive Plan, as may be amended from time to time (the ?Plan?), hereby grants to the holder listed below (?Participant?), an option to purchase the number of shares of the Company?s Common Stock (the ?Shares?), set fort

Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance

Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance CAMPBELL, Calif.

Transchip Share Purchase and Shareholders Agreement, dated September 15, 2022

SHARE PURCHASE AND SHAREHOLDERS AGREEMENT among Arteris HK Limited Transchip Technology (Nanjing) Co.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2022 Employment Inducement Award Plan

ARTERIS INC. 2022 EMPLOYMENT INDUCEMENT INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE Arteris Inc., a Delaware corporation, (the ?Company?), pursuant to its 2022 Employment Inducement Incentive Plan, as may be amended from time to time (the ?Plan?), hereby grants to the holder listed below (?Participant?), an award of restricted stock units (?Restricted Stock Units? or ?RSUs?). Each vest

2022 Employment Inducement Award Plan

ARTERIS INC. 2022 EMPLOYMENT INDUCEMENT INCENTIVE PLAN ARTICLE I. PURPOSE The Plan?s purpose is to enhance the Company?s ability to attract, retain and motivate eligible employees, who are expected to make important contributions to the Company or any Subsidiaries, by providing these individuals with equity ownership opportunities. ARTICLE II. DEFINITIONS As used in the Plan, the following words a

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 8, 2022 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Nu

Arteris Announces Financial Results for the Second Quarter 2022 and Estimated Third Quarter and Full Year 2022 Guidance

Arteris Announces Financial Results for the Second Quarter 2022 and Estimated Third Quarter and Full Year 2022 Guidance CAMPBELL, Calif.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 9, 2022 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): June 14, 2022 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numbe

Transchip Share Purchase and Shareholders Agreement, dated February 21, 2022

SHARE PURCHASE AND SHAREHOLDERS AGREEMENT among Arteris HK Limited Transchip Technology (Nanjing) Co.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

Arteris Announces Financial Results for the First Quarter 2022 and Estimated Second Quarter and Full Year 2022 Guidance

Arteris Announces Financial Results for the First Quarter 2022 and Estimated Second Quarter and Full Year 2022 Guidance CAMPBELL, Calif.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): May 10, 2022 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEF 14A 1 d323776ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 31, 2022 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numb

As filed with the Securities and Exchange Commission on March 7, 2022

As filed with the Securities and Exchange Commission on March 7, 2022 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-409

Contractor’s Assignment of Independent Contractor Services Agreement as Amended, from Isabelle Geday to Magillem Design Services S.A., effective as of January 10, 2022

Assignment of ICSA 1. Confidential CONTRACTOR?S ASSIGNMENT OF INDEPENDENT CONTRACTOR SERVICES AGREEMENT AS AMENDED, FROM ISABELLE GEDAY TO MAGILLEM DESIGN SERVICES S.A. This Contractor?s Assignment of Independent Contractor Services agreement as Amended, from Isabelle Geday to Magillem Design Services S.A. and Restated Project Assignment 1 (?ICSA Assignment?) is agreed, confirmed and ratified to b

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Table Form S-8 (Form Type) Arteris, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, $0.001 par value pe

Subsidiaries of Arteris, Inc.

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People?s Republic of China Transchip Technology (Nanjing) Co., Ltd. People?s Republic of China Arteris IP Korea Limited Korea Arteris K.K. Japan Arteris IP, SAS France Resident Representative Office of Foreign (Region) Enterprise in China People?s Re

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2021 and Estimated First Quarter and Full Year 2022 Guidance

Arteris Announces Financial Results for the Fourth Quarter and Full Year 2021 and Estimated First Quarter and Full Year 2022 Guidance CAMPBELL, Calif.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): March 3, 2022 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Numbe

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2022 ARTERIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Nu

US04302A1043 / Arteris, Inc. / Bayview Legacy, LLC - SC 13G Passive Investment

Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to ? 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04302A104 (CUSIP Number) December 31, 2

US04302A1043 / Arteris, Inc. / Ventech Capital F - SC 13G Passive Investment

Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to ? 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Arteris, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 04302A104 (CUSIP Number) December 31, 2

JOINT FILING AGREEMENT

Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2021 ARTERIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Nu

Amended and Restated Project Assignment 1 to Independent Contractor Services Agreement

Exhibit 10.1 Consultant: Isabelle Geday AMENDED AND RESTATED PROJECT ASSIGNMENT 1 TO INDEPENDENT CONTRACTOR SERVICES AGREEMENT THIS AMENDED AND RESTATED PROJECT ASSIGNMENT 1 (?Amended Project 1?) is agreed, confirmed and ratified to be entered into as of August 16, 2021 (?Amended Project 1 Effective Date?) between Arteris, Inc., a corporation having its principal place of business at 595 Millich D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): November 30, 2021 ARTERIS, INC. (Exact name of Registrant, as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File N

Arteris Announces Financial Results for the Third Quarter 2021 and Estimated Fourth Quarter and Full Year 2021 Guidance

Arteris Announces Financial Results for the Third Quarter 2021 and Estimated Fourth Quarter and Full Year 2021 Guidance CAMPBELL, Calif.

2021 Employee Stock Purchase Plan

Exhibit 99.3 ARTERIS INC. 2021 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1 PURPOSE The Plan?s purpose is to assist employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company, and to help such employees provide for their future security and to encourage them to remain in the employment of the Company and its Subsidiaries. The Plan consists of two comp

As filed with the Securities and Exchange Commission on October 29, 2021

As filed with the Securities and Exchange Commission on October 29, 2021 Registration No.

Arteris, Inc. 2016 Equity Incentive Plan and related form agreements, as amended.

Exhibit 99.1(a) ARTERIS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 30, 2013 APPROVED BY THE STOCKHOLDERS: DECEMBER 30, 2013 AMENDED BY THE BOARD OF DIRECTORS: FEBRUARY 5, 2016 AMENDMENT APPROVED BY THE STOCKHOLDERS: FEBRUARY 5, 2016 TERMINATION DATE: DECEMBER 30, 2023 1. GENERAL. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligibl

2021 Incentive Award Plan.

Exhibit 99.2A ARTERIS INC. 2021 INCENTIVE AWARD PLAN ARTICLE I. PURPOSE The Plan?s purpose is to enhance the Company?s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. ARTICLE II. DEFINITIONS As used in the Plan, the following words and phrases have the meani

Amended and Restated Bylaws of Arteris, Inc.

Exhibit 3.2 Amended and Restated Bylaws of Arteris, Inc. (a Delaware corporation) Table of Contents Page Article I?Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II?Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought before a Meeting 2 2.5 Notice of Nominations for Election to the Board of Direc

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2021 ARTERIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40960 27-0117058 (State or other jurisdiction of incorporation) (Commission File Num

Amended and Restated Certificate of Incorporation of Arteris, Inc.

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARTERIS, INC. Arteris, Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1. The name of the Corporation is Arteris, Inc. The Corporation was incorporated by the filing of its original Certificate of Incorporation with

5,000,000 Shares Arteris, Inc. Common Stock

Table of Contents Filed pursuant to Rule 424(b)(4) Registration No. 333-259988 PROSPECTUS 5,000,000 Shares Arteris, Inc. Common Stock This is an initial public offering of shares of common stock of Arteris, Inc. We are offering 5,000,000 shares of our common stock. Prior to this offering, there has been no public market for our common stock. The initial public offering price is $14.00 per share of

Arteris, Inc. 595 Millich Dr. Suite 200 Campbell, CA 95008

Arteris, Inc. 595 Millich Dr. Suite 200 Campbell, CA 95008 October 22, 2021 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Asia Timmons-Pierce Jay Ingram Mindy Hooker Kevin Stertzel Re: Arteris, Inc. Registration Statement on Form S-1 (Registration No. 333-259988) Ladies and Gentlemen:

As filed with the Securities and Exchange Commission on October 22, 2021

As filed with the Securities and Exchange Commission on October 22, 2021 Registration No.

Form of Underwriting Agreement.

Exhibit 1.1 Arteris, Inc. UNDERWRITING AGREEMENT [•], 2021 JEFFERIES LLC COWEN AND COMPANY, LLC As Representatives of the several Underwriters c/o JEFFERIES LLC 520 Madison Avenue New York, New York 10022 c/o COWEN AND COMPANY, LLC 599 Lexington Avenue New York, New York 10022 Ladies and Gentlemen: Introductory. Arteris, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to t

[Signature page follows]

October 22, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, D.C. 20549 Attention: Asia Timmons-Pierce Jay Ingram Mindy Hooker Kevin Stertzel Re: Arteris, Inc. Registration Statement on Form S-1 (File No. 333-259988) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulat

Form 8-A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ARTERIS, INC. (Exact name of registrant as specified in its charter) Delaware 27-0117058 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 595 Mi

Form of Amended and Restated Bylaws of Arteris, Inc., to be in effect immediately prior to the closing of this offering.

Exhibit 3.4 Amended and Restated Bylaws of Arteris, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought before a Meeting 2 2.5 Notice of Nominations for Election to the Board of D

Form of Amended and Restated Certificate of Incorporation of Arteris, Inc., to be in effect immediately prior to the closing of this offering.

Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARTERIS, INC. Arteris, Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1. The name of the Corporation is Arteris, Inc. The Corporation was incorporated by the filing of its original Certificate of Incorporation with

Form of Indemnification Agreement between Arteris, Inc. and its directors and officers.

Exhibit 10.19 INDEMNIFICATION AND ADVANCEMENT AGREEMENT This Indemnification and Advancement Agreement (?Agreement?) is made as of , 2021 by and between Arteris, Inc., a Delaware corporation (the ?Company?), and , [a member of the Board of Directors/an officer/an employee/an agent/a fiduciary] of the Company (?Indemnitee?). This Agreement supersedes and replaces any and all previous Agreements bet

Arteris, Inc. Non-Employee Director Compensation Policy.

Exhibit 10.18 ARTERIS INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM This Arteris Inc. (the ?Company?) Non-Employee Director Compensation Program (this ?Program?) has been adopted under the Company?s 2021 Incentive Award Plan (the ?Plan?) and shall be effective upon the date of the effectiveness of the registration statement on Form S-1 filed by the Company with the U.S. Securities and Exchange C

Form of Arteris, Inc. 2021 Incentive Award Plan.

Exhibit 10.13 ARTERIS INC. 2021 INCENTIVE AWARD PLAN ARTICLE I. PURPOSE The Plan?s purpose is to enhance the Company?s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. ARTICLE II. DEFINITIONS As used in the Plan, the following words and phrases have the meani

Form of Stock Option Award Agreement under Arteris, Inc. 2021 Incentive Award Plan.

Exhibit 10.14 ARTERIS INC. 2021 INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE Arteris Inc., a Delaware corporation, (the ?Company?), pursuant to its 2021 Incentive Award Plan, as may be amended from time to time (the ?Plan?), hereby grants to the holder listed below (?Participant?), an option to purchase the number of shares of the Company?s Common Stock (the ?Shares?), set forth below (the ?Opti

Subsidiaries of Arteris, Inc.

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris IP, SAS France

Form of Restricted Stock Unit Award Agreement under Arteris, Inc. 2021 Incentive Award Plan

Exhibit 10.15 ARTERIS INC. 2021 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE Arteris Inc., a Delaware corporation, (the ?Company?), pursuant to its 2021 Incentive Award Plan, as may be amended from time to time (the ?Plan?), hereby grants to the holder listed below (?Participant?), an award of restricted stock units (?Restricted Stock Units? or ?RSUs?). Each vested Restricted Stoc

As filed with the Securities and Exchange Commission on October 18, 2021

S-1/A 1 d52087ds1a.htm AMENDMENT NO. 1 TO FORM S-1 Table of Contents As filed with the Securities and Exchange Commission on October 18, 2021 Registration No. 333-259988 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ARTERIS, INC. (Exact name of registrant as specified in its charter) Delaware

Form of Executive Change in Control Severance Agreement

Exhibit 10.17 ARTERIS INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT This Change in Control and Severance Agreement (the ?Agreement?) is made and entered into by and between [] (?Executive?) and Arteris Inc. (the ?Company?), effective as of [the latest date set forth by the signatures of the parties hereto below]/[the date Executive commences employment with the Company] (the ?Effective Date?). Ba

2021 Employee Stock Purchase Plan

Exhibit 10.16 ARTERIS INC. 2021 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1 PURPOSE The Plan?s purpose is to assist employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company, and to help such employees provide for their future security and to encourage them to remain in the employment of the Company and its Subsidiaries. The Plan consists of two com

Specimen Stock Certificate evidencing the shares of common stock.

Exhibit 4.1 AR INCORPORATED UNDER THE CUSIP 04302A 10 4 LAWS OF THE STATE SEE REVERSE FOR CERTAIN OF DELAWARE DEFINITIONS AND LEGENDS This certifies that BY: AMERICAN COUNTERSIGNED is the record holder of STOCK AND FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.001 PAR VALUE PER SHARE, OF (BROOKLYN, ARTERIS, INC. TRANSFER transferable on the books of the Corporation in person or by duly a

Arteris Commission Agreement, dated April 10, 2017, by and between Arteris, Inc. and David Mertens.

EX-10.8 11 d52087dex108.htm EX-10.8 Exhibit 10.8 ARTERIS COMMISSION AGREEMENT 1. This document (the “Agreement”) memorializes the rules that the Arteris group of companies, including Arteris, Inc. Arteris IP, SAS, Arteris K.K., Arteris IP Korea, LLC, and Arteris, Inc. Shanghai Representative Office (each, as applicable, individually identified as the “Company”) shall follow when calculating and pa

Amended and Restated Certificate of Incorporation of Arteris, Inc., as amended and currently in effect.

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARTERIS, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Arteris, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), DOES HEREBY CERTIFY: 1. That the name of this corpo

Amendment to the Arteris Commission Agreement, dated as of January 1, 2020, by and between Arteris, Inc. and David Mertens.

EX-10.9 12 d52087dex109.htm EX-10.9 Exhibit 10.9 AMENDMENT TO THE ARTERIS COMMISSION AGREEMENT BETWEEN ARTERIS INC. AND DAVID MERTENS This amendment (“Amendment”) to the Arteris Commission Agreement between Arteris Inc. and David Mertens dated April 10, 2017 (“Agreement”) is effective as of January 1, 2020. WHEREAS, the parties desire to modify the rights and obligations set forth in the Agreement

License Agreement, dated as of October 11, 2013, by and between Arteris, Inc. and Qualcomm Technologies, Inc.

Exhibit 10.3 Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential. LICENSE AGREEMENT This LICENSE AGREEMENT (hereinafter referred to as the “Agreement”) is entered into on this 11th day of October, 2013, by and among Qualcomm Technologies, Inc.

Employment Agreement, by and between Arteris, Inc. and K. Charles Janac.

EX-10.6 9 d52087dex106.htm EX-10.6 Exhibit 10.6 Arteris, Inc. 1741 Technology Drive, Suite 250 San Jose, CA 95110 Fax: (408) 625-6040 www.arteris.com December 31, 2008 Mr. K. Charles Janac [Address] Re: Revised Terms of Employment Dear Charlie: This amended and restated letter agreement (“Agreement”) sets forth the terms of your employment with Arteris, Inc. (the “Company”). This letter has been a

Amended and Restated Business Financing Agreement, by and between Arteris, Inc. and Western Alliance Bank dated as of December 16, 2020.

Exhibit 10.2 AMENDED AND RESTATED BUSINESS FINANCING AGREEMENT Borrower: ARTERIS, INC. 595 Millich Drive Suite 200 Campbell, CA 95008 Lender: WESTERN ALLIANCE BANK, an Arizona corporation 55 Almaden Boulevard, Suite 100 San Jose, CA 95113 RECITALS A. Lender and Borrower have previously entered into that certain Business Financing Agreement dated as of August 3, 2015, as amended from time to time (

Investors’ Rights Agreement, dated February 5, 2016, by and among Arteris, Inc. and the investors listed therein.

Exhibit 10.1 ARTERIS, INC. INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (this ?Agreement?), is made as of the 5th day of February, 2016, by and among Arteris, Inc., a Delaware corporation (the ?Company?), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an ?Investor?, and each of the holders of the Company?s Common Stock, par value $0

Amended and Restated Bylaws of Arteris, Inc., as currently in effect.

Exhibit 3.3 AMENDED AND RESTATED BYLAWS OF ARTERIS, INC. (A DELAWARE CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be as determined by the Board of Directors from time to time. Section 2. Other Offices. The corporation shall also have and maintain an office or principal place of business at such place as may be

Office Lease, by and between Millich Commercial, LLC and Arteris, Inc., dated as of July 17, 2017.

EX-10.5 8 d52087dex105.htm EX-10.5 Exhibit 10.5 OFFICE LEASE Millich Commercial, LLC a California limited liability company as “Landlord” and Arteris, Inc. a Delaware corporation as “Tenant” OFFICE LEASE SUMMARY OF BASIC LEASE TERMS SECTION (LEASE REFERENCE) TERMS A. (Introduction) Lease Reference Date: July 17, 2017 B. (Introduction) Landlord: Millich Commercial, LLC, a California limited liabili

Offer Letter, dated as of March 23, 2010, by and between Arteris, Inc. and David Mertens.

Exhibit 10.7 Mr. David Mertens [****] March 23, 2010 Dear David, We have the pleasure to confirm to you our offer for the position of Vice President of Sales, Americas, Korea and Taiwan, starting on or about April 1, 2010, reporting directly to Charlie Janac, Arteris President and CEO. During the term of your employment, you will receive a fixed all-in annual gross salary of $160,000, and a commis

Arteris, Inc. 2013 Equity Incentive Plan and related form agreements, as amended.

Exhibit 10.11 ARTERIS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 30, 2013 APPROVED BY THE STOCKHOLDERS: DECEMBER 30, 2013 AMENDED BY THE BOARD OF DIRECTORS: FEBRUARY 5, 2016 AMENDMENT APPROVED BY THE STOCKHOLDERS: FEBRUARY 5, 2016 TERMINATION DATE: DECEMBER 30, 2023 1. GENERAL. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible

Subsidiaries of Arteris, Inc.

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People’s Republic of China TransChip Management Consultancy (Nanjing) Co., Ltd. People’s Republic of China Arteris IP Korea Limited Korea Arteris K.K. Japan Arteris IP, SAS France Resident Representative Office of Foreign (Region) Enterprise in China

Arteris, Inc. 2016 Equity Incentive Plan for the Grant of Restricted Stock Unit Awards to Employees in France.

Exhibit 10.12 RULES OF THE ARTERIS, INC. 2016 EQUITY INCENTIVE PLAN FOR THE GRANT OF RESTRICTED STOCK UNIT AWARDS TO EMPLOYEES IN FRANCE Dated October 10, 2016 1. Introduction. The Board of Directors (the “Board”) of Arteris, Inc. (the “Company”) has established the Arteris, Inc. 2016 Equity Incentive Plan (the “U.S. Plan”), as approved on October 10, 2016 by the stockholders of Arteris, Inc. , fo

Asset Purchase Agreement, dated as of October 9, 2013, by and among Qualcomm Technologies, Inc., Qualcomm France SARL, Arteris Holdings, Inc., Arteris, Inc. and Arteris, SAS

Exhibit 10.4 Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential ASSET PURCHASE AGREEMENT BY AND AMONG QUALCOMM TECHNOLOGIES, INC. QUALCOMM FRANCE SARL together as Acquiror, ARTERIS HOLDINGS, INC., ARTERIS, INC., AND ARTERIS, SAS OCTOBER 9, 20

Employment Agreement, by and between Arteris IP SAS and Isabelle Geday.

Exhibit 10.10 Dear Magillem France Employee, Arteris Onboarding Documents and Process We are looking forward to welcoming you as an employee of Arteris IP SAS (AIPSAS) on 1 December 2020! Please find attached the following documents: 1.  Employment Amendment Agreement (if applicable) please DocuSign 2.  Other Employment documents (if applicable) please DocuSign 3.  IP Assignment letter to Arteris

Power of Attorney (included on signature page of the initial filing of this registration statement).

Table of Contents As filed with the Securities and Exchange Commission on October 1, 2021 Registration No.

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARTERIS, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware)

EX-3.1 2 filename2.htm Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARTERIS, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) Arteris, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), DOES HEREBY CERTIFY: 1. That

OFFICE LEASE Millich Commercial, LLC a California limited liability company as “Landlord” Arteris, Inc. a Delaware corporation as “Tenant”

Exhibit 10.4 OFFICE LEASE Millich Commercial, LLC a California limited liability company as ?Landlord? and Arteris, Inc. a Delaware corporation as ?Tenant? OFFICE LEASE SUMMARY OF BASIC LEASE TERMS SECTION (LEASE REFERENCE) TERMS A. (Introduction) Lease Reference Date: July 17, 2017 B. (Introduction) Landlord: Millich Commercial, LLC, a California limited liability company C. (Introduction) Tenant

RULES OF THE ARTERIS, INC. 2016 EQUITY INCENTIVE PLAN FOR THE GRANT OF RESTRICTED STOCK UNIT AWARDS TO EMPLOYEES IN FRANCE Dated October 10, 2016

EX-10.9 8 filename8.htm Exhibit 10.9 RULES OF THE ARTERIS, INC. 2016 EQUITY INCENTIVE PLAN FOR THE GRANT OF RESTRICTED STOCK UNIT AWARDS TO EMPLOYEES IN FRANCE Dated October 10, 2016 1. Introduction. The Board of Directors (the “Board”) of Arteris, Inc. (the “Company”) has established the Arteris, Inc. 2016 Equity Incentive Plan (the “U.S. Plan”), as approved on October 10, 2016 by the stockholder

ARTERIS, INC. INVESTOR RIGHTS AGREEMENT

Exhibit 10.1 ARTERIS, INC. INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (this ?Agreement?), is made as of the 5th day of February, 2016, by and among Arteris, Inc., a Delaware corporation (the ?Company?), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an ?Investor?, and each of the holders of the Company?s Common Stock, par value $0

ARTERIS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 30, 2013 APPROVED BY THE STOCKHOLDERS: DECEMBER 30, 2013 AMENDED BY THE BOARD OF DIRECTORS: FEBRUARY 5, 2016 AMENDMENT APPROVED BY THE STOCKHOLDERS: FEBRUARY 5, 2016

EX-10.8 7 filename7.htm Exhibit 10.8 ARTERIS, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 30, 2013 APPROVED BY THE STOCKHOLDERS: DECEMBER 30, 2013 AMENDED BY THE BOARD OF DIRECTORS: FEBRUARY 5, 2016 AMENDMENT APPROVED BY THE STOCKHOLDERS: FEBRUARY 5, 2016 TERMINATION DATE: DECEMBER 30, 2023 1. GENERAL. (a) Eligible Stock Award Recipients. Employees, Directors and Co

Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People’s Republic of China TransChip Management Consultancy (Nanjing) Co., Ltd. People’s Republic of China Arteri

Exhibit 21.1 Subsidiaries of Arteris, Inc. Legal Name of Subsidiary Jurisdiction of Organization Arteris Semiconductor Technology (Nanjing) Co., Ltd. People?s Republic of China TransChip Management Consultancy (Nanjing) Co., Ltd. People?s Republic of China Arteris IP Korea Limited Korea Arteris K.K. Japan Arteris IP, SAS France Resident Representative Office of Foreign (Region) Enterprise in China

AMENDED AND RESTATED BYLAWS ARTERIS, INC. (A DELAWARE CORPORATION) ARTICLE I

EX-3.3 3 filename3.htm Exhibit 3.3 AMENDED AND RESTATED BYLAWS OF ARTERIS, INC. (A DELAWARE CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be as determined by the Board of Directors from time to time. Section 2. Other Offices. The corporation shall also have and maintain an office or principal place of business a

AMENDED AND RESTATED BUSINESS FINANCING AGREEMENT Borrower: ARTERIS, INC. 595 Millich Drive Suite 200 Campbell, CA 95008 Lender: WESTERN ALLIANCE BANK, an Arizona corporation 55 Almaden Boulevard, Suite 100 San Jose, CA 95113

EX-10.2 5 filename5.htm Exhibit 10.2 AMENDED AND RESTATED BUSINESS FINANCING AGREEMENT Borrower: ARTERIS, INC. 595 Millich Drive Suite 200 Campbell, CA 95008 Lender: WESTERN ALLIANCE BANK, an Arizona corporation 55 Almaden Boulevard, Suite 100 San Jose, CA 95113 RECITALS A. Lender and Borrower have previously entered into that certain Business Financing Agreement dated as of August 3, 2015, as ame

As confidentially submitted to the Securities and Exchange Commission on August 20, 2021 This Amendment No. 2 to the draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remai

Table of Contents As confidentially submitted to the Securities and Exchange Commission on August 20, 2021 This Amendment No.

* * *

DRSLTR 1 filename1.htm 505 Montgomery Street, Suite 2000 San Francisco, California 94111-6538 Tel: +1.415.391.0600 Fax: +1.415.395.8095 www.lw.com FIRM / AFFILIATE OFFICES August 20, 2021 Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Sh

As confidentially submitted to the Securities and Exchange Commission on July 26, 2021 This Amendment No. 1 to the draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains

Table of Contents As confidentially submitted to the Securities and Exchange Commission on July 26, 2021 This Amendment No.

* * *

DRSLTR 1 filename1.htm 505 Montgomery Street, Suite 2000 San Francisco, California 94111-6538 Tel: +1.415.391.0600 Fax: +1.415.395.8095 www.lw.com FIRM / AFFILIATE OFFICES July 26, 2021 Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shan

As confidentially submitted to the Securities and Exchange Commission on June 11, 2021 This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential

Table of Contents As confidentially submitted to the Securities and Exchange Commission on June 11, 2021 This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential Registration No.